Pay in 4 interest-free payments of $7.39 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
Global GLP-1 Receptor Agonist Market Size, Share, and COVID-19 Impact Analysis, By Drug Class (Semaglutide, Dulaglutide, Liraglutide, Exenatide), By Type (Victoza, Ozempic, Saxenda, Trulicity, Bydureon), By Application (Type 2 Diabetes, Obesity, and Others), By Route of Administration (Parenteral and Oral), By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2022 2032 Industry: Healthcare Global GLP-1 Receptor Agonist Market Insights Forecasts to 2032 The Global GLP-1 Receptor Agonist Market Size was valued at USD 13.4 Billion in 2022
Figure 3 In another study comparing the neuroprotective effects of two other novel GLP-1/GIP dual receptor agonists (DA-JC4, DA-CH5) with the GLP-1 single receptor agonist liraglutide and the first-generation GLP-1/GIP dual receptor agonist DA-JC1 in MPTP-induced PD mice, the results concluded that the new dual receptor agonists have clear neuroprotective effects (112)
(2019b)
Never freeze Wegovy, and keep it away from direct sunlight and heat
Krger, N., Reuther, T., Williams, S., & Kerscher, M
Several factors determine how quickly any individual responds
